IMMUNOTHERAPY IN ONCOLOGY

APAVAC IN ONCOLOGY

APAVAC is indicated in the treatment of many different tumor types.

What are the clinical outcomes of APAVAC in human medicine?

APAVAC protocol applied in humans showed that there was no systemic side effect, that activation of cellular immunity existed and could result in partial remission or stabilization without further treatment. The efficacy of APAVAC benefits from any means that is not immunosuppressive to reduce the tumor mass.

A series of twenty patients with different types of cancer at very advanced stages received immunotherapeutic treatment. These results have been published: A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and self-antigens in cancer patients. Ciocca DR, Frayssinet P, Cuello-Carrion FD. Cell Stress Chaperones. 2007 12(1):33-43

Interested in:

The lymphoma
The cancer